Skip to main navigation
axcella.com

Main navigation

  • About
    • About Us
    • Board & Leadership
    • Publications
    • Patents
  • EMMs
  • Platform
  • Pipeline
    • Our Pipeline
    • AXA1125
    • AXA1665
    • Expanded Access Policy
  • Investors & News
    • Corporate Profile
    • News Releases
    • Events and Presentations
    • Stock Information
    • Financials & Filings
    • Corporate Governance
  • Careers
  • Contact
  • Corporate Profile
  • News Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price
    • Investor Calculator
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Documents & Charters
    • Board & Leadership
    • Committee Composition

Event Details

Results from Phase 2a Clinical Trial for Long COVID

Aug 2, 2022 at 8:00 AM EDT

Listen to webcast

Supporting Materials

View Presentation 5.2 MB

Tools

Print
RSS Feeds
Email Alerts
Investor Contact
Search
Axcella Logo

840 Memorial Drive,
3rd Floor, Cambridge,
MA 02139

O: 857-320-2200
F: 617-441-6243
E: info@axcellatx.com

Footer

  • About
  • EMMs
  • Platform
  • Pipeline
  • Investors & News
  • Contact
  • Careers

Follow us at:

  • linkedin
Copyright © Axcella Therapeutics 2023 All rights reserved. | Terms of Use | Privacy Notice | Axcella and Axcella logo, AXA, EMMPOWER, and EMMPACT are trademarks of Axcella Health Inc. in the U.S. and/or other countries.